共 9 条
[1]
The role of OROS誖hydromorphone in the management of cancer pain. Gardner Nix J,Mercadante S. Pain Practice . 2010
[2]
Sustained safety and efficacy of once-daily hyd-romorphone extended-release (OROShydromorphone ER)compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain. RICHARZ U,WAECHTER S,SABATOWSKI R et al. Pain Pract . 2013
[3]
Continuous epidural bupivacaine hydromorphone infusion:does intraoperative initiation improve post-surgical analgesia?. SINATRA R,OCAMPO C,CHUNG K,et al. Anesthesia and Analgesia . 2001
[4]
Comparative clinical effects of hydromorphone and morphine: a meta-analysis. L. Felden,C. Walter,S. Harder. BRITISH JOURNAL OF ANAESTHESIA . 2011
[5]
Two milligrams i.v. hydromorphone is efficacious for treating pain but is associated with oxygen desaturation. Chang Andrew K,Bijur Polly E,Napolitano Antonio,Lupow Jason,Gallagher E John. Journal of opioid management . 2009
[6]
Prospective survey of patient-controlled epidural analgesia with bupivacaine and hydromorphone in 3736 postoperative orthopedic patients. Liu Spencer S,Bieltz Mihai,Wukovits Barbara,John Raymond S. Regional Anesthesia . 2010
[7]
A randomized, double-blind comparison of OROS? [!/sup]hydromorphone and controlled-release morphine for the control of chronic cancer pain. Hanna Magdi,Thipphawong John. BMC Palliative Care . 2008
[8]
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS? [!/sup]hydromorphone in patients with chronic cancer pain. Magdi Hanna,Alberto Tuca,John Thipphawong. BMC Palliative Care . 2009
[9]
Clinical efficacy of OROS(?) hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice. Stepanovi? Aleksander,Pirc Jelka,Lahajnar ?avlovi? Slavica. Wiener Klinische Wochenschrift . 2011